Skip to content

About
News
Clinicians
Patients
Research

Menu

About
News
Clinicians
Patients
Research

AMD Publications

All
Retina
Cornea
AMD
CNV
RVO
DME
ROP
Keratoconus
Dry Eye
Glaucoma

Menu

All
Retina
Cornea
AMD
CNV
RVO
DME
ROP
Keratoconus
Dry Eye
Glaucoma

Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes

Clinical and Experimental Ophthalmology

April 2022

International impact of the COVID-19 pandemic lockdown on intravitreal therapy outcomes: Fight Retinal Blindness registry

Retina

April 2022

The impact of disease activity on 5-year outcomes in patients undergoing treatment for neovascular age-related macular degeneration

Retina

January 2022

Three-Year Outcomes of Neovascular Age-Related Macular Degeneration in Eyes That Do Not Develop Macular Atrophy or Subretinal Fibrosis

Translational vision science & technology

November 2021

Extended intervals for wet AMD patients with high retreatment needs: informing the risk during COVID-19, data from real-world evidence

Eye

October 2021

Real-world treatment outcomes of neovascular Age-related Macular Degeneration in the Netherlands

Acta Ophthalmologica

September 2021

Neovascular age-related macular degeneration: A review of findings from the real-world Fight Retinal Blindness! registry

Clinical & Experimental Ophthalmology

September 2021

Neovascular age-related macular degeneration at treatment intervals of 14 weeks or greater

Clinical and Experimental Ophthalmology

August 2021

Association between anatomical and clinical outcomes of neovascular age-related macular degeneration treated with anti-VEGF

Retina

July 2021

Treat-and-extend versus fixed bimonthly treatment regimens for treatment-naive neovascular age-related macular degeneration: real world data from the Fight Retinal Blindness registry

Graefe’s Archive for Clinical and Experimental Ophthalmology

June 2021

Five-year incidence and visual acuity outcomes for intravitreal therapy in bilateral neovascular age-related macular degeneration: Fight Retinal Blindness! Project

Retina

January 2021

Lifetime Outcomes of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration

JAMA Ophthalmology

December 2020

« Previous Page1 Page2 Page3 Page4 Page5 Page6 Next »

Email: ssi.ssr@sydney.edu.au
Phone: (+61) 421 787 808

Level 1, South Block
Sydney Eye Hospital
8 Macquarie Street
Sydney NSW 2000

Follow us

X-twitter Facebook Youtube

Quick links

Contact Us
Donate Now

Contact Us
Donate Now